Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Therapy areas
Musculoskeletal
Musculoskeletal
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Musculoskeletal
Fulcrum Therapeutics Licenses Failed GSK Drug for Possible Muscular Dystrophy Indication
Biospace News
-
April 24, 2019
Musculoskeletal
Study links Celebrex, heart valve calcification after earlier research declared drug safe
Musculoskeletal
The delicate balance of treating growing but brittle bones
Musculoskeletal
Drug shows promise to treat diet-induced osteoarthritis
Musculoskeletal
Despite concerns, opioids remain legitimate pain medications, says Health Canada ...
- Advertisement -
MOST POPULAR
Completion of a Successful Management Buyout Transaction At NuChem Therapeutics
February 22, 2019
Sensorion Receives FDA IND Approval for Arazasetron (SENS-401)
July 12, 2019
Scottish Medicines Consortium rituximab (MabThera)
June 13, 2019
Sensorion announces oral presentation at the European Histamine Research Society
May 17, 2019
Load more
HOT NEWS
Deals
Enigma Biomedical Group Signs License Agreement with Merck for Novel MK-6884...
Commercial
4 Big Real Estate Buys Benefit Bay Area Biotechs
Commercial
Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial...
Commercial
Hysteroscopic Septum Resection Does Not Improve Live Birth Rates in Women...
